Addictive painkiller OxyContin being analyzed on U.

Addictive painkiller OxyContin being analyzed on U.S. Children Purdue Pharma LP, the pharmaceutical company in charge of developing the highly addictive painkiller drug OxyContin , is indeed desperate to retain exclusivity on the soon-to-expire patent legal rights for its drug that it has decided to conduct clinical trials with OxyContin in young children. Based on the Wall Road Journal , more than 150 children between the age groups of six and 16 will participate in the multi-site trial, which will be used solely to increase OxyContin’s exclusive patent by a mere six months.Medical scientists have known for some time that unhealthy lifestyle behaviors are a major, preventable contributor to the development of coronary artery disease. A study study group from Johns Hopkins University School of Medication have published the consequence of their function in the American Journal of Epidemiology that highlights a significant link between lifestyle factors and heart health, adding even more evidence in support of regular exercise, consuming a Mediterranean-style diet, keeping a standard weight and, most importantly, not smoking. Smoking cigarettes cessation is found to have the largest impact in lowering the chance of early deathRegarding the results of this study, lead author, Dr.